(Q37883970)

24 August 2017

1 reference

title

Insulin X10 revisited: a super-mitogenic insulin analogue (English)

1 reference

24 August 2017

1 reference

B F Hansen

1

1 reference

24 August 2017

P Kurtzhals

2

1 reference

24 August 2017

A B Jensen

3

1 reference

24 August 2017

A Dejgaard

4

1 reference

24 August 2017

D Russell-Jones

5

1 reference

24 August 2017

publication date

3 June 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

54

1 reference

24 August 2017

issue

9

1 reference

24 August 2017

page(s)

2226-2231

1 reference

A cohort study of the risk of cancer associated with type 2 diabetes

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Long-term metformin use is associated with decreased risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

A superactive insulin: [B10-aspartic acid]insulin(human).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Comparison of subcutaneous soluble human insulin and insulin analogues (AspB9, GluB27; AspB10; AspB28) on meal-related plasma glucose excursions in type I diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

ASPB10 insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: evidence for enhanced interactions with the insulin-like growth factor-I receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

In vitro metabolic and mitogenic signaling of insulin glargine and its metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

pI-shifted insulin analogs with extended in vivo time action and favorable receptor selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Insulin analogues and cancer risk: cause for concern or cause célèbre?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Synchronization in G0/G1 enhances the mitogenic response of cells overexpressing the human insulin receptor A isoform to insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Monomeric insulins obtained by protein engineering and their medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2203-8

Differences in the cellular processing of AspB10 human insulin compared with human insulin and LysB28ProB29 human insulin

21 January 2018

1 reference

12 December 2020

Modifications in the B10 and B26-30 regions of the B chain of human insulin alter affinity for the human IGF-I receptor more than for the insulin receptor

1 reference

12 December 2020

Insulin promotion of colon tumors in rats.

1 reference

12 December 2020

Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults

1 reference

12 December 2020

Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency

1 reference

12 December 2020

Systematic evaluation of the metabolic to mitogenic potency ratio for B10-substituted insulin analogues

1 reference

12 December 2020

Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells

1 reference

12 December 2020

Subcutaneous Insulin Absorption Explained by Insulin's Physicochemical Properties: Evidence From Absorption Studies of Soluble Human Insulin and Insulin Analogues in Humans

1 reference

12 December 2020

Receptor Binding and Tyrosine Kinase Activation by Insulin Analogues With Extreme Affinities Studied in Human Hepatoma HepG2 Cells

1 reference

12 December 2020

The bioactivity of insulin analogues from in vitro receptor binding to in vivo glucose uptake

1 reference

12 December 2020

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

1 reference

12 December 2020

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

1 reference

12 December 2020

10.1007/S00125-011-2203-8

Identifiers

DOI

1 reference

release_vigyet64wffjnechy44pgcns6y

24 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vigyet64wffjnechy44pgcns6y

24 November 2022

mapped directly with Wikidata item

1 reference